Brief: InDex Pharmaceuticals Q1 Oper Loss Widens To SEK 18.9 Mln
May 16 (Reuters) - InDex Pharmaceuticals Holding AB
INDEX.ST :
* Q1 NET SALES AMOUNTED TO SEK 0.0 (0.0) MILLION
* Q1 OPERATING LOSS AMOUNTED TO SEK 18.9 (LOSS 9.3) MILLION
Source text for Eikon: ID:nWkr8ZpQWr
Further company coverage: INDEX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Flerie AB
See all newsBrief: Flerie Q3 Net Asset Value SEK 3,113 Million
Brief: Flerie Portfolio Co Reports Positive Data From Clinical Proof-Of-Mechanism Study
Brief: Flerie Writes Down Value Of Holding In Empros Pharma
Brief: Nasdaq Approves Biosergen's Delisting Application
Brief: Flerie Approves Merger Plan For Flerie And Biosergen